CheckMate 9LA showed a 26% overall survival benefit for metastatic NSCLC patients treated with nivolumab and ipilimumab plus ...
Checkmate, a leading provider of unified ordering solutions for enterprise restaurants has secured $10 million in Series B funding, led by Tiger Global. The investment will be used to accelerate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results